Description: Our pioneering diagnostic and therapeutic products have practical applications in oncology, cardiology and more.
AZEDRA is the first and only approved treatment for advanced pheochromocytoma and paraganglioma.
Not an actual patient.
Sherry received AZEDRA treatment following pheochromocytoma recurrence. Watch the video to hear Sherry discuss her experience.